lead plaintiff deadline

751 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Plug Power Faces Securities Class Action Over DOE Loan Claims

Rosen Law Firm pursues securities lawsuit against $PLUG over alleged false statements regarding DOE loan and hydrogen facilities. April 3 deadline for investors.
PLUGinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Soleno Therapeutics Faces Securities Lawsuit Over PWS Drug Safety Claims

Securities class action filed against $SLNO over alleged false statements regarding safety risks in Phase 3 trial for Prader-Willi syndrome treatment. Lead plaintiff deadline: May 5, 2026.
SLNOsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Gartner Faces Securities Class Action Over Alleged Misstatements on Growth

Rosen Law Firm recruits Gartner investors for securities class action alleging false growth statements. Lead plaintiff deadline: May 18, 2026.
NAVNITBCSsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Lakeland Industries Faces Securities Class Action Over Pacific Helmets, Jolly Business Misstatements

Rosen Law Firm urges Lakeland Industries investors to meet April 24, 2026 lead plaintiff deadline in securities class action alleging false statements about Pacific Helmets and Jolly businesses.
LAKEsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Nektar Therapeutics Faces Securities Class Action Over Trial Enrollment Claims

Rosen Law Firm urges $NKTR investors to join class action lawsuit alleging false statements about REZOLVE-AA trial enrollment protocols caused significant shareholder losses.
NKTRsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PayPal Faces Securities Class Action Over Misleading 2027 Targets and Growth Claims

Investors in $PYPL who purchased stock between February 2025 and February 2026 may qualify for compensation in ongoing securities class action alleging false financial statements.
PYPLsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Trip.com Faces Securities Class Action Over Alleged Monopoly Disclosure Failures

Rosen Law Firm launches securities class action against $TCOM for alleged material misstatements regarding regulatory risks and monopolistic practices. Lead plaintiff deadline: May 11, 2026.
TCOMregulatory risksecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PomDoctor Investors Face April Deadline in Securities Fraud Class Action

$POM investors have until April 7, 2026 to join class action alleging fraud involving fake promotions, insider trading, and market manipulation.
POMsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Vital Farms Hit With Class Action Over ERP Delays and Missed Guidance

Rosen Law Firm files securities class action against $VITL over alleged false statements regarding ERP system rollout delays that caused missed earnings guidance.
VITLLUsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Class Action Against $LU on Behalf of Defrauded Investors

Rosen Law Firm filed a securities class action against Lufax Holding Ltd, alleging false statements and inadequate financial disclosures. Investors have until May 20, 2026 to join.
LUsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

monday.com Hit With Securities Lawsuit Over Growth Forecasts

Rosen Law Firm urges monday.com investors to meet May 2026 deadline in securities fraud lawsuit alleging false growth claims.
MNDYsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Picard Medical Investors Face April Deadline in Securities Fraud Class Action

Rosen Law Firm urges $PMI investors to join class action over alleged fraudulent stock promotion scheme involving social media misinformation and insider dumping.
PMIsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Corcept Faces Securities Lawsuit After FDA Rejection, $2.5B Market Wipeout

Hagens Berman sues $CORT over alleged concealment of FDA warnings on relacorilant. Stock crashed 50% following Complete Response Letter, erasing $2.5B in market value.
CORTsecurities class actionFDA rejection
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Navan Hit With Securities Suit Over Hidden Spending Surge in IPO Filings

Navan faces securities lawsuit over allegedly omitted $95M sales expense surge in IPO documents; stock down 63% from $25 offering price.
NAVNstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Suit Against ImmunityBio Over Anktiva Claims

Rosen Law Firm filed a class action lawsuit against ImmunityBio ($IBRX), alleging founder Patrick Soon-Shiong materially overstated Anktiva's capabilities, impacting investors.
KDRRIBRXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Kyndryl Faces Securities Class Action Over Alleged Disclosure Failures

Rosen Law Firm filed a securities class action against Kyndryl Holdings alleging false disclosures on financials and internal controls, with an April 2026 lead plaintiff deadline.
KDRRIBRXsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Richtech Robotics Faces Securities Lawsuit Over Alleged False Microsoft Partnership Claims

Rosen Law Firm files class action against Richtech Robotics ($RR) for allegedly misrepresenting Microsoft collaboration. Investors have until April 3 to join suit.
RRsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

REGENXBIO Faces Securities Lawsuit Over Gene Therapy Trial Disclosures

Rosen Law Firm recruits lead plaintiffs for securities class action against REGENXBIO over alleged false statements regarding RGX-111 gene therapy trial data. Lead plaintiff deadline: April 14, 2026.
RGNXsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

CIGL Stock Plummets 80% as Class Action Alleges Pump-and-Dump Scheme

Robbins LLP reminds investors of May 18, 2026 deadline to join class action against Concorde International Group ($CIGL) over alleged pump-and-dump scheme using social media misinformation.
CIGLsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

PSIX Faces Class Action Over Data Center Claims as Stock Plummets 29%

Law firm Robbins LLP urges $PSIX investors to act by May 19, 2026 deadline in class action alleging misleading data center projections and hidden manufacturing issues.
PSIXsecurities fraudclass action